{
     "PMID": "27455834",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170313",
     "LR": "20170313",
     "IS": "1477-3155 (Electronic) 1477-3155 (Linking)",
     "VI": "14",
     "IP": "1",
     "DP": "2016 Jul 25",
     "TI": "Gd-nanoparticles functionalization with specific peptides for ss-amyloid plaques targeting.",
     "PG": "60",
     "LID": "10.1186/s12951-016-0212-y [doi]",
     "AB": "BACKGROUND: Amyloidoses are characterized by the extracellular deposition of insoluble fibrillar proteinaceous aggregates highly organized into cross-beta structure and referred to as amyloid fibrils. Nowadays, the diagnosis of these diseases remains tedious and involves multiple examinations while an early and accurate protein typing is crucial for the patients' treatment. Routinely used neuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) using Pittsburgh compound B, [(11)C]PIB, provide structural information and allow to assess the amyloid burden, respectively, but cannot discriminate between different amyloid deposits. Therefore, the availability of efficient multimodal imaging nanoparticles targeting specific amyloid fibrils would provide a minimally-invasive imaging tool useful for amyloidoses typing and early diagnosis. In the present study, we have functionalized gadolinium-based MRI nanoparticles (AGuIX) with peptides highly specific for Abeta amyloid fibrils, LPFFD and KLVFF. The capacity of such nanoparticles grafted with peptide to discriminate among different amyloid proteins, was tested with Abeta(1-42) fibrils and with mutated-(V30M) transthyretin (TTR) fibrils. RESULTS: The results of surface plasmon resonance studies showed that both functionalized nanoparticles interact with Abeta(1-42) fibrils with equilibrium dissociation constant (Kd) values of 403 and 350 microM respectively, whilst they did not interact with V30M-TTR fibrils. Similar experiments, performed with PIB, displayed an interaction both with Abeta(1-42) fibrils and V30M-TTR fibrils, with Kd values of 6 and 10 microM respectively, confirming this agent as a general amyloid fibril marker. Thereafter, the ability of functionalized nanoparticle to target and bind selectively Abeta aggregates was further investigated by immunohistochemistry on AD like-neuropathology brain tissue. Pictures clearly indicated that KLVFF-grafted or LPFFD-grafted to AGuIX nanoparticle recognized and bound the Abeta amyloid plaque localized in the mouse hippocampus. CONCLUSION: These results constitute a first step for considering these functionalized nanoparticles as a valuable multimodal imaging tool to selectively discriminate and diagnose amyloidoses.",
     "FAU": [
          "Plissonneau, Marie",
          "Pansieri, Jonathan",
          "Heinrich-Balard, Laurence",
          "Morfin, Jean-Francois",
          "Stransky-Heilkron, Nathalie",
          "Rivory, Pascaline",
          "Mowat, Pierre",
          "Dumoulin, Mireille",
          "Cohen, Richard",
          "Allemann, Eric",
          "Tomicronth, Eva",
          "Saraiva, Maria Joao",
          "Louis, Cedric",
          "Tillement, Olivier",
          "Forge, Vincent",
          "Lux, Francois",
          "Marquette, Christel"
     ],
     "AU": [
          "Plissonneau M",
          "Pansieri J",
          "Heinrich-Balard L",
          "Morfin JF",
          "Stransky-Heilkron N",
          "Rivory P",
          "Mowat P",
          "Dumoulin M",
          "Cohen R",
          "Allemann E",
          "Tomicronth E",
          "Saraiva MJ",
          "Louis C",
          "Tillement O",
          "Forge V",
          "Lux F",
          "Marquette C"
     ],
     "AD": "Nano-H S.A.S, 38070, Saint Quentin Fallavier, France. Institut Lumiere Matiere, UMR5306 CNRS Universite Claude Bernard Lyon 1, Domaine Scientifique de La Doua, 2 rue Victor Grignard, 69622, Villeurbanne Cedex, France. Laboratoire de Chimie et Biologie des Metaux, Universite Grenoble Alpes, CEA Life Science Division, CNRS, 17 rue des Martyrs, 38054, Grenoble Cedex 9, France. Universite de Lyon, Lyon, France. ISPB Faculte de Pharmacie, 4bis-MATEIS UMR CNRS 5510, 69373, Lyon, France. Centre de biophysique moleculaire, UPR 4301, Rue Charles Sadron CS 80054, 45071, Orleans Cedex 2, France. School of pharmaceutical Sciences, University of Geneva, University of Lausanne Pharmaceutical technology, Quai Ernest-Ansermet 30, 1211, Geneva, Switzerland. Universite de Lyon, Lyon, France. ISPB Faculte de Pharmacie, 4bis-MATEIS UMR CNRS 5510, 69373, Lyon, France. Laboratoire de Chimie et Biologie des Metaux, Universite Grenoble Alpes, CEA Life Science Division, CNRS, 17 rue des Martyrs, 38054, Grenoble Cedex 9, France. Centre for Protein Engineering, Laboratory of Enzymology and Protein Folding Institut of Chemistry, B6 University of Liege Sart Tilman, 4000, Liege, Belgium. Universite de Lyon, Lyon, France. ISPB Faculte de Pharmacie, 4bis-MATEIS UMR CNRS 5510, 69373, Lyon, France. Laboratoire de Biochimie et de Biologie Moleculaire, Hospices Civils de Lyon, Lyon, France. School of pharmaceutical Sciences, University of Geneva, University of Lausanne Pharmaceutical technology, Quai Ernest-Ansermet 30, 1211, Geneva, Switzerland. Centre de biophysique moleculaire, UPR 4301, Rue Charles Sadron CS 80054, 45071, Orleans Cedex 2, France. Molecular Neurobiology Group, Institute of Biology, Molecular and Cellular, R. Campo Alegre 823, 4150, Porto, Portugal. Nano-H S.A.S, 38070, Saint Quentin Fallavier, France. Institut Lumiere Matiere, UMR5306 CNRS Universite Claude Bernard Lyon 1, Domaine Scientifique de La Doua, 2 rue Victor Grignard, 69622, Villeurbanne Cedex, France. Laboratoire de Chimie et Biologie des Metaux, Universite Grenoble Alpes, CEA Life Science Division, CNRS, 17 rue des Martyrs, 38054, Grenoble Cedex 9, France. Institut Lumiere Matiere, UMR5306 CNRS Universite Claude Bernard Lyon 1, Domaine Scientifique de La Doua, 2 rue Victor Grignard, 69622, Villeurbanne Cedex, France. Laboratoire de Chimie et Biologie des Metaux, Universite Grenoble Alpes, CEA Life Science Division, CNRS, 17 rue des Martyrs, 38054, Grenoble Cedex 9, France. christel.marquette@cea.fr.",
     "AUID": [
          "ORCID: http://orcid.org/0000-0002-0640-3025"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20160725",
     "PL": "England",
     "TA": "J Nanobiotechnology",
     "JT": "Journal of nanobiotechnology",
     "JID": "101152208",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Peptide Fragments)",
          "0 (Peptides)",
          "0 (Prealbumin)",
          "0 (amyloid beta-protein (1-42))",
          "AU0V1LM3JT (Gadolinium)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/*diagnostic imaging/metabolism/pathology",
          "Amyloid beta-Peptides/*chemistry/metabolism",
          "Animals",
          "Disease Models, Animal",
          "Female",
          "Gadolinium/*chemistry",
          "Gene Expression",
          "Hippocampus/*metabolism/ultrastructure",
          "Humans",
          "Kinetics",
          "Magnetic Resonance Imaging",
          "Metal Nanoparticles/*chemistry",
          "Mice",
          "Mice, Transgenic",
          "Mutation",
          "Peptide Fragments/*chemistry/metabolism",
          "Peptides/chemical synthesis/metabolism",
          "Plaque, Amyloid/*diagnostic imaging/metabolism/pathology",
          "Prealbumin/*chemistry/metabolism",
          "Protein Binding",
          "Surface Plasmon Resonance"
     ],
     "PMC": "PMC4960888",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer's disease",
          "Amyloid imaging",
          "Beta-amyloid fibrils",
          "Gadolinium based nanoparticles",
          "MRI contrast agent",
          "Peptide-targeting"
     ],
     "EDAT": "2016/07/28 06:00",
     "MHDA": "2017/03/14 06:00",
     "CRDT": [
          "2016/07/27 06:00"
     ],
     "PHST": [
          "2016/05/03 00:00 [received]",
          "2016/07/06 00:00 [accepted]",
          "2016/07/27 06:00 [entrez]",
          "2016/07/28 06:00 [pubmed]",
          "2017/03/14 06:00 [medline]"
     ],
     "AID": [
          "10.1186/s12951-016-0212-y [doi]",
          "10.1186/s12951-016-0212-y [pii]"
     ],
     "PST": "epublish",
     "SO": "J Nanobiotechnology. 2016 Jul 25;14(1):60. doi: 10.1186/s12951-016-0212-y.",
     "term": "hippocampus"
}